Category: Joint ventures/collaborations
-
Commercial Data Yield Genetic Links to Depression
An analysis of data from commercial genetic tests identified 15 regions in the genome and 17 specific variations associated with depression among people of European descent.
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.
-
Open-Source Discovery Yields Anti-Malaria Candidates
A worldwide research project tested 400 compounds as anti-malarial drugs, which led to more than 30 new drug development programs for malaria and other diseases.
-
Cancer Center Tests Mobile Patient Tracking
Memorial Sloan Kettering Cancer Center in New York is evaluating mobile devices to track the quality of life experienced by multiple myeloma patients.
-
Stem Cells, Gene Therapy Produce Replacement Joint Cartilage
A process combining stem cells, industrial weaving, and gene therapy to grow replacement cartilage for osteoarthritis also prevents inflammation from returning.
-
High-Volume, More Efficient Stem Cell Production Developed
An academic-industry team in Europe designed and tested new processes that can simplify and streamline production of human stem cells in large quantities.
-
Danforth Center, Valent Partner on Underground Plant Imaging
A plant science center and crop science company are developing a large-scale X-ray imaging system to measure root development in plants.
-
Company, Charity to Discover Antibiotic Boosters
An organization promoting research on drug-resistant bacteria is collaborating with a drug discovery company on compounds that reverse antibiotic resistance.
-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.